
Ocugen to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, announced it will present at the H.C. Wainwright …
Read More